Tratamiento de las arritmias cardíacas durante el embarazo

Medicina Clinica

Volumn 107, Issue 1, 1996, Pages 29-36

  Blanco, Victor Manuel Rodríguez ^a,b   Álvarez, Vicente Barriales ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0043140593     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (125)

1. Rotmensch HH, Elkayam U, Frishman W Antiarrhythmic drug therapy during pregnancy Ann Intern Med 1983; 98: 487-497
2. Morganroth J. Proarrhythmic effects of antiarrhythmic drugs envolving concepts. Am Heart J 1992; 123: 1.137-1 139
3. Falk RH. Proarrhythmia in patents treated for atrial fibrillation or flutter Ann Intern Med 1992, 117. 141-150.
4. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized contrat trials. Circulation 1990; 82: 1 106-1.116
5. Levy G. Pharmacokinetics of fetal and neonatal exposure to drugs. Obstet Gynecol 1981, 58 (Supl 5) 9-16.
6. Mitani GM, Steinberg I, Lien J, Harrison EC, Elkayam U. The Pharmacokinetics of antiarrhythmic agents in pregnancy and lactation Clin Pharmacokinet 1987, 12: 253-291
7. Platzker ACD, Lew CD, Stewars D Drug administration via breast milk Hosp Pract 1980; 15: 111-122
8. Berlin CM. Pharmacologic considerations of drug use in the lactating mother Obstet Gynecol 1981, 58 (Supl). 17-23
9. Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 1993; 36: 137-178
10. Eriksson M, Catz CS, Jaffa SJ Drugs and pregnancy Clin Obstet Gynecol 1973; 16: 199-224
11. Stern L. In vivo assessment of the teratogenic potential of drugs in humans Obstet Gynecol 1981; 58 (Supl) 3-8
12. Krauer B, Krauer F. Drug kinetics in pregnancy. Pharmacokinet 1977; 2. 167-181
13. Cole PL, Sutton MSJ. Normal cardiopulmonary adjustments to pregnancy cardiovascular evaluation Cardiovasc Clin 1989, 19: 37-56
14. Dean M, Stock B, Patterson RJ Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther 1980; 28 253-261.
15. Barriales V, Martínez Trabanco I, Cardiopatía y embarazo Med Clin (Barc) 1990; 94: 389-395
16. Stoch BH. Drug disposition in pregnancy. Pharm Int 1981; 2. 60-63.
17. Lees KR, Rubin PC Treatment of cardiovascular diseases Br Med J 1987; 294 358-360.
18. Nishihara K. Therapeutic drug monitoring of digoxin, Nippon Rinsho 1990; 48 1 165-1 168
19. Schlebusch H, Mende S, Grunn U, Gembruch U, Bald R, Hansmann M Determination of digoxin in the blood of pregnant women, fetuses and neonates before and during anti-arrhythmic therapy, using for inmunochemical methods. Eur J Clin Chem Clin Biochem 1991; 29 57-66
20. Rotmensch HH, Rotmensch S, Elkayam U. Management of cardiac arrhythmias during pregnancy Drugs 1987; 33. 623-633.
21. Weaver JB, Pearson JF. Influence of digitalis on time of onset and duration of labour in women with cardiac disease. Br Med J 1973, 3: 519-520.
22. +-ATPase activity in human placenta. Am J Physiol 1980; 238 38-45
23. Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv 1985, 40: 61-68
24. Wladimiroff JW, Stewart A Treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985, 34: 134-140.
25. Anderson JL, Harrison DC, Meffin PJ, Winkle RA. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. Drugs 1978, 15: 271-309
26. Mason JW, Hondghem LM, Quinidine. Ann NY Acad Sci 1984; 432 162-176.
27. Meyer J, Lackner JE, Schochet SS. Paroxysmal tachycardia in pregnancy JAMA 1930; 94. 1.901-1.904.
28. Hill LM, Malkasian GD. The use of quinidine sulfate throughout pregnancy. Obstet Gynecol 1979; 54 366-368.
29. Mauer AM, Devaux LO, Lakey ME Neonatal and maternal thrombocytopenic purpura due to quinidine. Pediatrics 1957; 19. 84-87.
30. Giardina EG. Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias. Ann NY Acad Sci 1984; 432: 177-188.
31. Connolly SJ, Kates RE. Clinical pharmacokinetics of N-acetylprocainamide. Clin Pharmacokinetic 1982; 7: 206-220
32. Keefe DL, Kates RE, Harrison DC. New antiarrhythmic drugs their place in therapy. Drugs 1981, 22. 363-400
33. Heel RC, Brogden RN, Speight TM Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs 1987; 15: 331-368
34. Wright JT. Practical pharmacokinetics of ventricular antiarrhythmic therapy. Am Heart J 1992; 123: 1.148-1.152.
35. Echizen H, Nakura M, Saotome T, Minoura S, Ishizaki T. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers. Br J Clin Pharmacol 1990, 29. 423-430.
36. Karim A, Cook C, Campion J Placental and milk transfer of disopyramide and its metabolites in rats Drug Metab Dispos 1978; 6: 346-348
37. Tadmor OP, Keren A, Rosenak D, Gal M, Shaia M, Hornstein E et al. The effect of disopyramide on uterine contractions during pregnancy Am J Obstet Gynecol 1990, 162. 482-486.
38. Singh BN, Collett JT, Chew CYC. New perspectives in pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980, 22: 243-301
39. Sherif IH, Oyan WT, Bosairi S, Carrascal SM. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand 1991. 70 46-63.
40. Bott-Kanner G, Schweitzer A, Reisner SH, Joel-Cohen SJ, Rosenfeld JB Propranolol and hydralazine in the management of essential hypertension in pregnancy. Br J Obstet Gynaecol 1980; 87: 110-114.
41. Rubin PC Beta-blockers in pregnancy. N Engl J Med 1981; 305. 1.323-1.326.
42. Smith MT, Livingstone I, Hooper WD. Propranolol, propranolol glucoronide, and naphthoxylactic acid in the breast milk and plasma. Ther Drug Monit 1983, 5: 87-93
43. Kulas J, Lunell NO, Rosing U Atenolol and metoprolol a comparison of their excretion into human breast milk. Acta Obstet Gynecol Scand 1984; 118: 65-69.
44. O'Hare MF, Kinney CD, Murnaghan GA. Pharmacokinetics of propranolol during pregnancy. Eur J Clin Pharmacol 1984; 27: 583-587.
45. Frishman WH, Chesner M. Bela-blockers in pregnancy Am Heart J 1988, 115 147-152.
46. Livingstone I, Craswell PW, Bevan EB. Propranolol in pregnancy, three year prospective study. Clin Exp Hypertens 1983; 2: 341-350.
47. Taylor EA, Turner P. Antihypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J 1981; 57: 427-430.
48. Blaker S, MacDonald D The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment Br J Obstet Gynaecol 1991; 98: 244-248.
49. Benfield P, Clissold SP, Brogden RN. Metoprolol: an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders Drugs 1986; 31: 376-429.
50. Hogstedt S, Lindberd B, Peng DR, Regardh CG, Rane A. Pregnancy-induced increase in metoprolol metabolism. Clin Pharmacol Ther 1985; 37: 688-692.
51. Wichman K, Ryden G, Karlberg BE A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scan J Clin Lab Invest 1984; 44 (Supl 169) 90-95
52. Singh BN, Deedwania P, Nademanee K, Ward A, Sorkin EM. Sotalol: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1987, 34. 311-349.
53. Hackett LP, Wojnar-Horton RE, Dusci LI Excretion of sotalol during pregnancy. Eur J Clin Pharmacol 1983, 24: 521-524
54. Lubbe WF, Hodge JV. Combined alfa and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. NZ Med 1981; 94: 169-172
55. Wadworth AN, Murdoch D, Brogden RN Atenolol a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders Drugs 1991; 42: 468-510
56. Montan S, Liedholm H, Lingman G, Marsal K. Sjöberg NO, Solum T. Fetal and utero placenta haemodynamics during short-term atenolol treatment of hypertension in pregnancy Br J Obstet Gynaecol 1987; 94. 312-317.
57. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J 1990; 301: 587-589.
58. Fabregues G, Alvarez L, Varas Juri P, Drisaldi S, Cerrato C, Moschettoni C et al. Effectiveness of atenoiol in the treatment of hypertension during pregnancy. Hypertension 1992; 19. 129-131.
59. Tuimala R, Hartikainen-Sorri AL Randomized comparison of atenolol and pindolol for treatment of hypertension in pregnancy. Curr Ther Res 1988, 44: 579-584
60. Singh BN, Thoden WR, Ward A Acebutolol: a review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia Drugs 1985, 29 531-569.
61. Roberts LG, Laborde JB, Slikker W. Phenytoin teratogenicity and mid-gestational pharmacokinetics in mice. Teratology 1991, 44: 497-505
62. Kelly TE Teratogenicuty of anticonvulsivant drugs. Review of the literature. Am J Med Genet 1987; 19: 413-434.
63. Nakane Y, Okuma T, Takashashi R. Multiinstitutional study on the teratogenicity and fetal toxicity of antiepileptic drugs, a report of a collaborative group in Japan. Epilepsia 1980; 21. 663-680.
64. Truog WE, Feusner JH, Baker DL Association of haemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome. J Pediatr 1980; 96. 112-114.
65. Allen RW, Ogden B, Bently FL, Jang AL. Fetal hydantoin syndrome, neuroblastoma and haemorrhagic disease in a neonate. JAMA 1980, 244 1 464-1.465
66. Byerly WG, Hartmann A, Foster DE, Tannenbaum AK Verapamil in the treatment of maternal paroxysmal supraventicular tachycardia Ann Emerg Med 1991: 20 552-554
67. Ulmsten U Inhibition of myometrial hyperactivity by Ca antagonists. Dan Med Bull 1979; 26: 125-126.
68. McTavish D, Sorkin EM Verapamil an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs 1989; 38: 19-76.
69. Elkayam U Pregnancy and cardiovascular disease En: Braunwald E, editor. Heart Disease: a textbook of cardiovascular medicine. Filadelfia: WB Saunders, 1992; 1 790-1 809
70. Bloedow DC, Ralston PH, Hargrove SC. Lidocaine pharmacokinetics in pregnant and nonpregnant sheep. J Pharm Sci 1980, 69 32-37
71. Biehl D, Schnider SM, Levinson G, Callender K. Placental transfer of lidocaine. effects of fetal acidosis Anesthesiology 1978; 48: 409-412.
72. Gill J, Heel RC, Fitton A. Amiodarone: an overview of its pharmacological properties and review of its therapeutic use in cardiac arrhythmias. Drugs 1992; 43. 69-110.
73. Pitcher D, Leather HM, Storey GC, Holt DW Amiodarone in pregnancy Lancet 1983, 1 597-598.
74. Valensise H, Civitella C, Garzetti GC, Romanini C. Amiodarone treatment in pregnancy for dilative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome Prenat Diagn 1992, 12: 705-708.
75. De Wolf D, De Schepper J, Verhaaren H, Deneyer M, Smitz J. SacreSmits L. Congenital hypothyroid goiter and amiodarone Acta Paedriatr Scand 1988, 77. 616-618.
76. McKenna WJ, Harris L, Rowland E, Whitelaw A, Storey G. Holt D. Amiodarone therapy during pregnancy. Am J Cardiol 1983, 51: 1 231-1.233.
77. Penn I, Barrett PA, Pannikote V, Barnaby PF, Campbell JB, Lyons NR. Amiodarone in pregnancy. Am J Cardiol 1985, 56. 196-197
78. Foster CJ, Love HG Amiodarone in pregnancy case report and review of literature Int J Cardiol 1988, 20: 307-316.
79. Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 1991, 122. 1.162-1.165.
80. Plomp TA, Vulsma T, De Vijlder JJ. Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol 1992, 43: 201-207
81. Strunge P, Frandsen J, Andreasen F. Amiodarone during pregnancy. Eur Heart J 1988, 9 106-109.
82. Roden DM, Woosley RL Flecamide N Engl J Med 1986; 315: 36-41
83. Doig JC, McComb JM, Reid DS. Incessant atrial tachycardia accelerated by pregnancy. Br Heart J 1992, 67: 266-268.
84. Yabek SM, Kato R, Ikeda N, Singh BN, Phil D. Effects of flecainide on the cellular electrophysiology of neonatal and adult cardiac fibers Am Heart J 1987; 113 70-76
85. Wren C, Campbell RWF The response of paediatric arrhythmias to intravenous and oral flecainide Br Heart J 1987; (Supl 7): 171-175.
86. Perry JC, McQuinn RL, Smith RT, Gothing C, Fredell P, Garson A. Flecainide acetate for resistant arrhythmias in the young, efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14: 185-191
87. Wren C, Hunter S Maternal adminisiration of flecainide to terminate and suppress fetal tachycardia. Br Med J 1988, 296: 249.
88. Allan LD, Chita SK, Sharland JK, Maxwell D, Priestley K Flecainide in the treatment of fetal tachycardias Br Heart J 1991, 65: 46-48
89. Perry JC, Ayres NA, Carpenter RJ Fetal supraventricular tachycardia treated with flecainide acetate. J Pediatr 1991; 118. 303-305
90. Palmer CM, Norris MC. Placental transfer of flecainide. Am J Dis Child 1990; 140. 144.
91. Wagner X, Jougjard J, Moulin M, Miller AM, Petitjean Y, Pisapia A Co-administration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta and excretion in human breast milk Am Heart J 1990; 119 700-702.
92. Funck-Brentano C, Kroemer HK, Lee JT, Roden DM Propafenone. N Engl J Med 1990; 322: 518-525.
93. Brunozzi LT, Meniconi L, Chiocchi P, Liberati R, Zuanetti G, Latini R. Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient Br J Clin Pharmacol 1988, 26 489-490
94. Libardoni M, Piovan D, Busato E, Padrini R Transfer of propafenone and 5-OH-propafenone to fetal plasma and maternal milk Br J Clin Pharmacol 1991, 32: 527-528
95. Mananim PJ. Pharmacotherapy of pregnancy-related STV Ann Emerg Med 1992; 21 229-230.
96. Faulds D, Chrisp P, Buckley MMT. Adenosine: an evaluation of its use in cardiac diagnosis procedures, and in the treatment of paroxysmal supraventricular tachycardia Drugs 1991; 41 596-624
97. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Plate E et al Adenosine for paroxysmal supraventricular tachycardia dose ranging and comparison with verapamil Ann Intern Med 1990, 113 104-110
98. Camm AJ, Garratt CJ Adenosine and supraventricular tachycardia N Engl J Med 1991, 325. 1.621-1 629.
99. Rankin AC, Brooks R, Ruskin JN, McGovern BA. Adenosine in the treatment of supraventricular tachycardia Am J Med 1992; 92: 655-664.
100. Harrison JK, Greenfield RA, Wharton JM Acute termination of supraventricular tachycardia by adenosine during pregnancy. Am Heart J 1992; 123: 1 386-1.388
101. Mason BA, Goodman JR, Koos BJ, Phil D Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. Obstet Gynecol 1992, 80: 478-480.
102. Afndi I, Moise KJ, Rokey R Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolf-Parkinson-White syndrome. Obstet Gynecol 1992, 80 481-483.
103. Cushley M, Tattersfield A, Holgate S. Adenosine induced bronchoconstriction in asthma. Am Rev Respir Dis 1984; 129: 380-384.
104. Lerman BB, Belardmelli L. Cardiac electrophysiology of adenosine Basic and clinical concepts Circulation 1991; 83: 1.499-1 504.
105. Podoslky SM, Varan J. Adenosine use during pregnancy Ann Emerg Med 1991; 20: 1 027-1.028.
106. Leffler S, Johnson DR. Adenosine use in pregnancy: lack of effect on fetal heart rate. Am J Emerg Med 1992; 10: 548-549.
107. Merson N. Adenosine treatment of supraventricular tachycardia following epiduraltest dose: a case study. AANA J 1993; 61: 521-523
108. Notterman DA. Inotropic agents: catecholamines, digoxin, amrinone. Crit Care Clin 1991; 7: 583-586.
109. Klepper I. Cardioversion in late pregnancy: the anaesthetic management of a case of Wolff-Parkinson-White syndrome Anaesthesia 1981; 36: 611-614.
110. Hubbard WN, Jenkins BA, Ward DE. Persistent atrial tachycardia in pregnancy. Br Med J 1983, 287 327.
111. DeSilva RA, Graboys TB, Podrid PJ, Lown B. Cardioversion and desfibrillation. Am Heart J 1980, 100: 881-895.
112. Jaffe R, Gruber A, Fejgin M, Altaras M, Ben-Aderet N. Pregnancy with and artificial pacemaker. Obstet Gynecol Surv 1987; 42: 137-139
113. Eddy WA, Frankenfeld RH. Congenital complete heart block in pregnancy Am J Obstet Gynecol 1977, 128: 223-225.
114. Esscher EB. Congenital complete heart block in adolescence and adult life: a follow-up study Eur Heart J 1981, 2: 281-288.
115. Amikam S, Abramovici H, Brandes JM Pregnancy in the presence of an implanted pacemaker. Int Surg 1982, 66: 369-371.
116. Widerhorn J, Widerhorn ALM, Rahimtoola SH, Elkayam U. WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J 1992; 123: 796-798.
117. Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993; 72: 838-840.
118. Brodsky M, Dona R, Allen B, Sato D, Thomas G, Sada M New-onset ventricular tachycardia during pregnancy Am Heart J 1992, 123: 933-941.
119. Brodsky MA, Sato DA, Oster PD, Schmith PS, Chesnic BM, Henry WL Paroxysmal ventricular tachycardia with syncope during pregnancy. Am J Cardiol 1986; 58: 563-564.
120. Vlay SC. Catecholamine-sensitive ventricular tachycardia. Am Heart J 1987, 114 455-461.
121. Brodsky MA, Allen BJ, Luckett CR, Capparelli EV, Wolff U, Henry WL Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmias Am Heart J 1989; 118. 272-280.
122. Buxton AE, Marchlinski FE, Doherty JU, Cassidy DM, Vassallo JA, Flores BT et al. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease Am J Cardiol 1984; 54: 997-1 002
123. Rey E, Bachrach LK, Burrow GN. Effects of amiodarone during pregnancy. Can Med Assoc J 1987; 136. 959-960.
124. Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985, 312: 1.432-1 437.
125. Kenmure AC, Cameron AJ Congenital complete heart block in pregnancy. Br Heart J 1967; 29: 910-912.